JR-441

· JCR Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JR-441, covering 2025-08-26 to 2025-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA [Phase 1, Phase 2]